Exact Sciences (EXAS) Enterprise Value: 2009-2025
Historic Enterprise Value for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $9.4 billion.
- Exact Sciences' Enterprise Value fell 19.12% to $9.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year decrease of 27.39%. This contributed to the annual value of $9.4 billion for FY2024, which is 25.71% down from last year.
- Per Exact Sciences' latest filing, its Enterprise Value stood at $9.4 billion for Q3 2025, which was up 2.06% from $9.2 billion recorded in Q2 2025.
- Exact Sciences' 5-year Enterprise Value high stood at $20.9 billion for Q1 2021, and its period low was $5.1 billion during Q3 2022.
- In the last 3 years, Exact Sciences' Enterprise Value had a median value of $11.4 billion in 2023 and averaged $10.7 billion.
- In the last 5 years, Exact Sciences' Enterprise Value soared by 184.38% in 2021 and then slumped by 69.02% in 2022.
- Over the past 5 years, Exact Sciences' Enterprise Value (Quarterly) stood at $12.4 billion in 2021, then slumped by 34.05% to $8.2 billion in 2022, then soared by 54.34% to $12.6 billion in 2023, then declined by 25.71% to $9.4 billion in 2024, then decreased by 19.12% to $9.4 billion in 2025.
- Its Enterprise Value was $9.4 billion in Q3 2025, compared to $9.2 billion in Q2 2025 and $7.3 billion in Q1 2025.